Cough, Cold and Allergy (Hay Fever) Remedies in South Africa

Date: October 18, 2017
Pages: 18
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C56F516D583EN
Leaflet:

Download PDF Leaflet

Cough, cold and allergy (hay fever) remedies continued to record double-digit current value growth in 2017, albeit slower than in previous years. Category growth continued to be fuelled by new product development and increasing self-medication. Economic uncertainty, characterised by high unemployment, falling disposable incomes and job insecurity, made it harder for people to take time off work to go to the doctor, with it also being cheaper to buy over-the-counter medicines.

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in South Africa report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Prospects
Economic Uncertainty and A Willingness To Self-medicate Drive Category Growth
High Incidence of Hiv and Climatic Conditions Drive Growth in Antihistamines/allergy Remedies
Competitive Landscape
Adcock Ingram Maintains Its Leading Position
Multinationals Dominate Sales Although Traditional Medicine Has A Strong Foothold in Rural South Africa
Private Label Relatively Small But Growing
Category Data
  Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2012-2017
  Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2012-2017
  Table 3 Sales of Decongestants by Category: Value 2012-2017
  Table 4 Sales of Decongestants by Category: % Value Growth 2012-2017
  Table 5 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2013-2017
  Table 6 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2017
  Table 7 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
  Table 8 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022
Executive Summary
Self-medication and Challenging Economic Climate Impact Growth
Uncertainty Persists Surrounding Amendments To the Complementary and Alternative Medicines (cams) Act
Adcock Ingram Maintains Its Leading Position in A Fragmented Industry
Chemists/pharmacies Remains the Leading Distribution Channel
Health and Wellness and Self-medication Trends Open Up New Opportunities for Consumer Health Players
Market Indicators
  Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  Table 10 Life Expectancy at Birth 2012-2017
Market Data
  Table 11 Sales of Consumer Health by Category: Value 2012-2017
  Table 12 Sales of Consumer Health by Category: % Value Growth 2012-2017
  Table 13 NBO Company Shares of Consumer Health: % Value 2013-2017
  Table 14 LBN Brand Shares of Consumer Health: % Value 2014-2017
  Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
  Table 16 Distribution of Consumer Health by Format: % Value 2012-2017
  Table 17 Distribution of Consumer Health by Format and Category: % Value 2017
  Table 18 Forecast Sales of Consumer Health by Category: Value 2017-2022
  Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
  Summary 1 Research Sources
Skip to top


Ask Your Question

Cough, Cold and Allergy (Hay Fever) Remedies in South Africa
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: